1. Academic Validation
  2. Binding profile of SM-9018, a novel antipsychotic candidate

Binding profile of SM-9018, a novel antipsychotic candidate

  • Jpn J Pharmacol. 1990 Dec;54(4):478-81. doi: 10.1254/jjp.54.478.
T Kato 1 A Hirose Y Ohno H Shimizu H Tanaka M Nakamura
Affiliations

Affiliation

  • 1 Research Laboratories, Sumitomo Pharmaceuticals, Co., Ltd., Osaka, Japan.
Abstract

The present study employed various receptor-binding assays to clarify the biochemical characteristics of SM-9018. SM-9018 possessed very high affinity for 5-HT2, D2 and 5-HT1A receptors (Ki = 0.61, 1.4 and 2.9 nM, respectively), and it had moderate affinity for alpha 1 and D1 receptors (Ki = 17 and 41 nM, respectively). However, SM-9018 had only negligible affinity for alpha 2, opiate, glutamate, phencyclidine, benzodiazepine and GABAA receptors. These results suggest that SM-9018 may be a novel antipsychotic agent with binding affinity for 5-HT2 and 5-HT1A receptors.

Figures
Products